Variant report

Variant	nsv1004482
Chromosome Location	chr2:96408987-96596717
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:692)
CpG islands
(count:122)
Chromatin interactive
region (count:0)
LncRNA
region (count:27)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:692 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:96521076-96521271	K562	blood:	n/a	n/a
2	ATF1	chr2:96595249-96595443	K562	blood:	n/a	n/a
3	ATF1	chr2:96517700-96517757	K562	blood:	n/a	n/a
4	BACH1	chr2:96492683-96492753	K562	blood:	n/a	n/a
5	BACH1	chr2:96526429-96526517	K562	blood:	n/a	n/a
6	BATF	chr2:96491153-96491435	GM12878	blood:	n/a	n/a
7	BATF	chr2:96533155-96533370	GM12878	blood:	n/a	n/a
8	BCL11A	chr2:96594562-96594761	GM12878	blood:	n/a	n/a
9	BCL11A	chr2:96442951-96443157	GM12878	blood:	n/a	n/a
10	BCL3	chr2:96468045-96468276	GM12878	blood:	n/a	n/a
11	BHLHE40	chr2:96533093-96533344	HepG2	liver:	n/a	n/a
12	BHLHE40	chr2:96557498-96557706	HepG2	liver:	n/a	n/a
13	BRCA1	chr2:96526629-96526661	GM12878	blood:	n/a	n/a
14	BRCA1	chr2:96577237-96577420	Hela-S3	cervix:	n/a	n/a
15	CBX3	chr2:96432533-96432779	K562	blood:	n/a	n/a
16	CEBPB	chr2:96556161-96556364	HepG2	liver:	n/a	n/a
17	CEBPB	chr2:96577216-96577553	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr2:96504906-96504952	HepG2	liver:	n/a	n/a
19	CEBPB	chr2:96556081-96556287	IMR90	lung:	n/a	n/a
20	CEBPB	chr2:96426837-96427246	IMR90	lung:	n/a	chr2:96427040-96427051
21	CEBPB	chr2:96479121-96479321	IMR90	lung:	n/a	n/a
22	CEBPB	chr2:96426902-96427182	MCF-7	breast:	n/a	chr2:96427040-96427051
23	CEBPB	chr2:96426884-96427208	Hela-S3	cervix:	n/a	chr2:96427040-96427051
24	CEBPB	chr2:96482692-96482778	HepG2	liver:	n/a	n/a
25	CEBPB	chr2:96482679-96482785	A549	lung:	n/a	n/a
26	CEBPB	chr2:96426939-96427088	HepG2	liver:	n/a	chr2:96427040-96427051
27	CEBPB	chr2:96576685-96576797	A549	lung:	n/a	n/a
28	CEBPB	chr2:96556160-96556378	A549	lung:	n/a	n/a
29	CHD2	chr2:96577302-96577508	Hela-S3	cervix:	n/a	n/a
30	CTCF	chr2:96456136-96456175	MCF-7	breast:	n/a	n/a
31	CTCF	chr2:96467670-96467699	Kidney_OC	kidney:	n/a	n/a
32	CTCF	chr2:96456044-96456195	Gliobla	brain:	n/a	n/a
33	CTCF	chr2:96456084-96456247	Pancreas_OC	pancreas:	n/a	n/a
34	CTCF	chr2:96440973-96441108	Hela-S3	cervix:	n/a	chr2:96441089-96441107
35	CTCF	chr2:96440896-96441277	K562	blood:	n/a	chr2:96441089-96441107
36	CTCF	chr2:96441001-96441166	Pancreas_OC	pancreas:	n/a	chr2:96441089-96441107
37	CTCF	chr2:96465489-96465587	K562	blood:	n/a	n/a
38	CTCF	chr2:96440965-96441298	A549	lung:	n/a	chr2:96441089-96441107
39	CTCF	chr2:96440989-96441106	HepG2	liver:	n/a	n/a
40	CTCF	chr2:96463771-96463856	GM10266	blood:	n/a	n/a
41	CTCF	chr2:96463343-96463356	LNCaP	prostate:	n/a	n/a
42	CTCF	chr2:96441003-96441218	A549	lung:	n/a	chr2:96441089-96441107
43	CTCF	chr2:96440740-96440890	HA-sp	spinal cord:	n/a	n/a
44	CTCF	chr2:96456415-96456497	GM19238	blood:	n/a	n/a
45	CTCF	chr2:96427990-96428021	Kidney_OC	kidney:	n/a	n/a
46	CTCF	chr2:96435737-96435747	LNCaP	prostate:	n/a	n/a
47	CTCF	chr2:96494215-96494281	LNCaP	prostate:	n/a	n/a
48	CTCF	chr2:96456561-96456562	HepG2	liver:	n/a	n/a
49	CTCF	chr2:96450566-96450579	GM13976	blood:	n/a	n/a
50	CTCF	chr2:96420529-96420569	GM13976	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:96427173-96427223	HCPEpiC	choroid plexus:	n/a
2	chr2:96427173-96427223	GM12892	blood:	n/a
3	chr2:96458247-96458297	AG04450	lung:	fetal
4	chr2:96458247-96458297	NB4	blood:	n/a
5	chr2:96427173-96427223	GM06990	blood:	n/a
6	chr2:96458247-96458297	BE2_C	brain:	n/a
7	chr2:96458247-96458297	HCT-116	colon:	n/a
8	chr2:96427173-96427223	HUVEC	blood vessel:	n/a
9	chr2:96427173-96427223	HRPEpiC	eye:	n/a
10	chr2:96427173-96427223	CMK	blood:	n/a
11	chr2:96458247-96458297	AG10803	skin:	n/a
12	chr2:96458247-96458297	SK-N-SH_RA	brain:	n/a
13	chr2:96427173-96427223	Caco-2	colon:	n/a
14	chr2:96458247-96458297	HRCEpiC	kidney:	n/a
15	chr2:96427173-96427223	SK-N-SH	brain:	n/a
16	chr2:96427173-96427223	SAEC	small airway:	n/a
17	chr2:96458247-96458297	Hepatocyte	liver:	n/a
18	chr2:96427173-96427223	HMEC	breast:	n/a
19	chr2:96427173-96427223	HCF	heart:	n/a
20	chr2:96458247-96458297	HCPEpiC	choroid plexus:	n/a
21	chr2:96427173-96427223	HRCEpiC	kidney:	n/a
22	chr2:96427173-96427223	HAEpiC	amniotic membrane:	n/a
23	chr2:96458247-96458297	HIPEpiC	eye:	n/a
24	chr2:96427173-96427223	PFSK-1	brain:	n/a
25	chr2:96458247-96458297	SAEC	small airway:	n/a
26	chr2:96427173-96427223	GM12891	blood:	n/a
27	chr2:96458247-96458297	PrEC	prostate:	n/a
28	chr2:96458247-96458297	HPAEpiC	pulmonary alveolar:	n/a
29	chr2:96458247-96458297	BJ	skin:	n/a
30	chr2:96427173-96427223	IMR90	lung:	fetal
31	chr2:96458247-96458297	NT2-D1	testis:	n/a
32	chr2:96458247-96458297	SK-N-SH	brain:	n/a
33	chr2:96458247-96458297	GM12891	blood:	n/a
34	chr2:96458247-96458297	HepG2	liver:	n/a
35	chr2:96458247-96458297	AoSMC	blood vessel:	n/a
36	chr2:96427173-96427223	NH-A	brain:	n/a
37	chr2:96458247-96458297	Caco-2	colon:	n/a
38	chr2:96427173-96427223	ProgFib	skin:	n/a
39	chr2:96427173-96427223	BE2_C	brain:	n/a
40	chr2:96458247-96458297	HAEpiC	amniotic membrane:	n/a
41	chr2:96458247-96458297	HRPEpiC	eye:	n/a
42	chr2:96427173-96427223	Jurkat	blood:	n/a
43	chr2:96458247-96458297	CMK	blood:	n/a
44	chr2:96427173-96427223	A549	lung:	n/a
45	chr2:96458247-96458297	HMEC	breast:	n/a
46	chr2:96427173-96427223	NB4	blood:	n/a
47	chr2:96458247-96458297	MCF-7	breast:	n/a
48	chr2:96458247-96458297	HNPCEpiC	eye:	n/a
49	chr2:96458247-96458297	IMR90	lung:	fetal
50	chr2:96458247-96458297	GM19239	blood:	n/a

No data

(count:27 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GPAT2-6	chr2:96523088-96523240	NONHSAT072520
2	lnc-ANKRD36C-1	chr2:96480419-96480840	NONHSAT072516
3	lnc-ANKRD36C-1	chr2:96479798-96486944	NONHSAT072513
4	lnc-TRIM43-2	chr2:96479803-96480574	NONHSAT072515
5	lnc-TRIM43-2	chr2:96479687-96479710	NONHSAT072515
6	lnc-ANKRD36C-1	chr2:96479810-96479882	NONHSAT072516
7	lnc-ANKRD36C-1	chr2:96480419-96480524	ENSG00000232931
8	lnc-ANKRD36C-1	chr2:96479558-96479705	NONHSAT072514
9	lnc-ANKRD36C-1	chr2:96472800-96473050	NONHSAT072509
10	lnc-ANKRD36C-1	chr2:96479079-96479705	NONHSAT072513
11	lnc-ANKRD36C-1	chr2:96489949-96492729	NONHSAT072509
12	lnc-ANKRD36C-1	chr2:96472866-96473050	ENSG00000232931
13	lnc-GPAT2-5	chr2:96557405-96557647	ucscGeneNc_uc002swd_1
14	lnc-ANKRD36C-1	chr2:96479064-96479281	ENSG00000232931
15	lnc-ANKRD36C-1	chr2:96479798-96482510	NONHSAT072510
16	lnc-ANKRD36C-1	chr2:96472813-96473050	NONHSAT072510
17	lnc-ANKRD36C-1	chr2:96479798-96479893	ENSG00000232931
18	lnc-ANKRD36C-1	chr2:96479798-96479893	NONHSAT072509
19	lnc-TRIM43-2	chr2:96479581-96479705	XLOC_001576
20	lnc-ANKRD36C-1	chr2:96479657-96479705	ENSG00000232931
21	lnc-ANKRD36C-1	chr2:96479174-96479284	NONHSAT072514
22	lnc-GPAT2-5	chr2:96559198-96559313	ucscGeneNc_uc002swd_1
23	lnc-GPAT2-5	chr2:96561691-96561770	ucscGeneNc_uc002swd_1
24	lnc-TRIM43-2	chr2:96477742-96477871	XLOC_001576
25	lnc-GPAT2-6	chr2:96533188-96533219	NONHSAT072520
26	lnc-ANKRD36C-1	chr2:96479798-96482417	NONHSAT072514
27	lnc-GPAT2-6	chr2:96525609-96525822	NONHSAT072520

No data

Variant related genes	Relation type
ENSG00000237510	TF binding region
LINC00342	TF binding region
ANKRD36C	TF binding region
ENSG00000237510	CpG island
LINC00342	CpG island
ANKRD36C	CpG island
SACS	miRNA target sites
KIF23	miRNA target sites

Extended variants
information (count: 5496 )
Associated
traits (count: 52 )

Variant overlapped rSNPs/rCNVs (count:5496 , 50 per page) page: 1 2 3 4 5 6 7 ... 110

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs535366527	chr2:96417473-96417474	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs555597603	chr2:96417479-96417480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs572366273	chr2:96417484-96417485	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs533461888	chr2:96417515-96417516	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs190335151	chr2:96417534-96417535	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs144425015	chr2:96417565-96417566	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs71427047	chr2:96417566-96417567	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs543930316	chr2:96417588-96417589	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs563875939	chr2:96417589-96417590	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs139207434	chr2:96417593-96417594	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs4096918	chr2:96417608-96417609	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs559720572	chr2:96417610-96417611	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs559965672	chr2:96417631-96417632	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs528757485	chr2:96417651-96417652	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs146500043	chr2:96417667-96417668	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs182505584	chr2:96417698-96417699	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs532911316	chr2:96417715-96417716	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs549422019	chr2:96417722-96417723	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs569526656	chr2:96417732-96417733	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs529053412	chr2:96417739-96417740	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs376448913	chr2:96417771-96417772	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs186751412	chr2:96417775-96417776	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs565994703	chr2:96417802-96417803	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs72492163	chr2:96417816-96417817	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
25	rs558225381	chr2:96417856-96417857	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs190665362	chr2:96417879-96417880	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs537551973	chr2:96417898-96417899	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs182395143	chr2:96417945-96417946	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs574305227	chr2:96417981-96417982	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs543231768	chr2:96418081-96418082	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs185485475	chr2:96418093-96418094	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs573518448	chr2:96418104-96418105	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs563724805	chr2:96418135-96418136	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs545377333	chr2:96418161-96418162	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs563744510	chr2:96418162-96418163	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs532728511	chr2:96418163-96418164	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs374482230	chr2:96418194-96418195	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs10198238	chr2:96418262-96418263	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs531059631	chr2:96418278-96418279	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs563016820	chr2:96418279-96418280	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs528960873	chr2:96418283-96418284	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs189604772	chr2:96418293-96418294	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs182632982	chr2:96418351-96418352	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7594390	chr2:96418352-96418353	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs188001708	chr2:96418360-96418361	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs76928906	chr2:96418406-96418407	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs571682321	chr2:96418433-96418434	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs193056774	chr2:96418443-96418444	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs7603758	chr2:96418476-96418477	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs567779094	chr2:96418487-96418488	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:52)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Neuroblastoma	18574593	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21509527	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Epilepsy	22083797	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1260 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:96417400-96417600	Enhancers	HSMMtube	muscle
2	chr2:96417400-96417800	Enhancers	Fetal Muscle Trunk	muscle
3	chr2:96417400-96419000	Enhancers	Brain Germinal Matrix	brain
4	chr2:96417400-96420200	Enhancers	Fetal Muscle Leg	muscle
5	chr2:96417600-96418600	Weak transcription	HSMMtube	muscle
6	chr2:96417800-96418400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr2:96418400-96419800	Enhancers	Fetal Muscle Trunk	muscle
8	chr2:96418600-96420000	Enhancers	HSMMtube	muscle
9	chr2:96419000-96419400	Weak transcription	Brain Germinal Matrix	brain
10	chr2:96419400-96419800	Enhancers	Brain Germinal Matrix	brain
11	chr2:96419400-96420200	Enhancers	Muscle Satellite Cultured Cells	--
12	chr2:96419600-96419800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr2:96419600-96420000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr2:96419600-96420000	Enhancers	NH-A	brain
15	chr2:96419800-96420000	Enhancers	Brain Anterior Caudate	brain
16	chr2:96419800-96420400	Enhancers	HSMM	muscle
17	chr2:96419800-96421800	Weak transcription	Fetal Muscle Trunk	muscle
18	chr2:96420200-96421800	Weak transcription	Fetal Muscle Leg	muscle
19	chr2:96421800-96422200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr2:96421800-96422400	Enhancers	Brain Anterior Caudate	brain
21	chr2:96421800-96422400	Enhancers	Fetal Muscle Trunk	muscle
22	chr2:96422200-96422400	Enhancers	Fetal Muscle Leg	muscle
23	chr2:96422400-96426200	Weak transcription	Brain Anterior Caudate	brain
24	chr2:96426200-96427200	Enhancers	Muscle Satellite Cultured Cells	--
25	chr2:96426200-96427400	Enhancers	Placenta Amnion	Placenta Amnion
26	chr2:96426200-96427600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr2:96426200-96427600	Enhancers	Brain Anterior Caudate	brain
28	chr2:96426200-96428200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr2:96426400-96427400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr2:96426400-96427400	Enhancers	HSMMtube	muscle
31	chr2:96426400-96427600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr2:96426400-96427600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr2:96426600-96427200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr2:96426600-96427200	Enhancers	Osteobl	bone
35	chr2:96426600-96427400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
36	chr2:96426600-96427400	Enhancers	HMEC	breast
37	chr2:96426600-96427400	Enhancers	HSMM	muscle
38	chr2:96426600-96427400	Enhancers	NH-A	brain
39	chr2:96426600-96427600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr2:96426600-96427600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr2:96426600-96428400	Enhancers	Placenta	Placenta
42	chr2:96427000-96427600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr2:96427400-96428800	Weak transcription	Placenta Amnion	Placenta Amnion
44	chr2:96427600-96428800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr2:96427600-96430800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr2:96428800-96429000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr2:96428800-96429800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr2:96429000-96429200	Enhancers	Placenta Amnion	Placenta Amnion
49	chr2:96429000-96429800	Enhancers	Fetal Muscle Trunk	muscle
50	chr2:96430400-96430600	Enhancers	Fetal Muscle Trunk	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links